Article
Contribution of APOBEC3G/F activity to the development of low-abundance drug-resistant human immunodeficiency virus type 1 variants.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases - 1 Feb 2016
Noguera-Julian M, Cozzi-Lepri A, Di Giallonardo F, Schuurman R, Däumer M, Aitken S, Ceccherini-Silberstein F, D'Arminio Monforte A, Geretti A M, Booth C L, Kaiser R, Michalik C, Jansen K, Masquelier B, Bellecave P, Kouyos R D, Castro E, Furrer H, Schultze A, Günthard H F, Brun-Vezinet F, Metzner K J, Paredes R
Abstract excerpt
Plasma drug-resistant minority human immunodeficiency virus type 1 variants (DRMVs) increase the risk of virological failure to first-line non-nucleoside reverse transcriptase inhibitor antiretroviral therapy (ART). The origin of DRMVs in ART-naive patients, however, remains unclear. In a large pan-European case-control study investigating the clinical relevance of pre-existing DRMVs using 454 pyrosequencing, the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
